A Single Center, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK376501 on Hepatic Cytochrome P450 Activity in Healthy Adult Subjects
Latest Information Update: 27 Jun 2023
At a glance
- Drugs GSK 376501 (Primary) ; Flurbiprofen; Midazolam; Rosiglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 26 Feb 2008 New trial record.